Drugs / platelet-poor plasma
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01639144 Comparator | Jul 2012 → Jan 2015 | — | Gary M. Kiebzak, Ph.D. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | platelet-poor plasma | “This will be a prospective, randomized study with patients blinded to either receiving platelet-rich plasma (PRP) and platelet-poor plasma (PPP) treatment or no treatment.” NCT01639144 ↗ |
| Known as | PPP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01639144 ↗ |